Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/466649

National Population and Cost Implications of Treatment with Icosapentyl Ethyl in the United States: An Assessment Based on the REDUCE-IT trial

Khera, R.·Valero-Elizondo, J.·Saxena, A.·Virani, S. S.·Krumholz, H. M.·Nasir, K.
View original source ↗Export metadata ↓

Abstract

Icosapent ethyl, an omega-3-fatty acid, was associated with improved cardiovascular outcomes in individuals with elevated levels of serum triglycerides and at a high-risk of adverse cardiovascular events in the recently completed REDUCE-IT trial. We applied the eligibility criteria of the REDUCE-IT trial to a nationally representative sample of individuals in the United States captured in the National Health and Nutrition Examination Survey (NHANES) for a 6-year period (2009-2014) and estimated the number of individuals nationally that would be potentially eligible for treatment with icosapentyl ethyl. We found that nearly 3 million US adults would potentially be candidates for this therapy. Further, based on the list cost of the drug, if all eligible individuals are treated, the additional cost to the US healthcare system will be almost $9 billion a year.

Explore related subjects

epidemiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Khera, R., Valero-Elizondo, J., Saxena, A., Virani, S. S., Krumholz, H. M., Nasir, K.. 2018-11-09. National Population and Cost Implications of Treatment with Icosapentyl Ethyl in the United States: An Assessment Based on the REDUCE-IT trial. https://doi.org/10.1101/466649

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2018

The role of African buffalo in the epidemiology of foot-and-mouth disease in sympatric cattle and buffalo populations in Kenya

Transmission of pathogens at wildlife-livestock interfaces poses a substantial challenge to the control of infectious diseases, including for foot-and-mouth disease virus (FMDV) in African buffalo and cattle. The extent to which buffalo play a role in the epidemiology of this virus in livestock populations remains unresolved in East Africa. Here, we show that FMDV occurs at high seroprevalence (~77%) in Kenyan buffalo. In addition, we recovered 80 FMDV VP1 sequences from buffalo, all of which were serotype SAT1 and SAT2, and seventeen FMDV VP1 sequences from cattle, which included serotypes A, O, SAT1 and SAT2. Notably, six individual buffalo were co-infected with both SAT1 and SAT2 serotypes. Our results suggest that transmission of FMDV between sympatric cattle and buffalo is rare. However, viruses from FMDV outbreaks in cattle elsewhere in Kenya were caused by viruses closely related to SAT1 and SAT2 viruses found in buffalo. We also show that the circulation of FMDV in buffalo is influenced by fine-scale geographic features, such as rivers, and that social segregation amongst sympatric herds may limit between-herd transmission. Our results significantly advance knowledge of the ecology and molecular epidemiology of FMDV at wildlife-livestock interfaces in Eastern Africa, and will help to inform the design of control and surveillance strategies for this disease in the region.

epidemiology↗
bioRxiv2018

Rigorous surveillance is necessary for high confidence in end-of-outbreak declarations for Ebola and other infectious diseases

The World Health Organization considers an Ebola outbreak to have ended once 42 days have passed since the last possible exposure to a confirmed case. Benefits of a quick end-of-outbreak declaration, such as reductions in trade/travel restrictions, must be balanced against the chance of flare-ups from undetected residual cases. We show how epidemiological modelling can be used to estimate the surveillance level required for decision-makers to be confident that an outbreak is over. Results from a simple model characterising an Ebola outbreak suggest that a surveillance sensitivity (i.e. case reporting percentage) of 79% is necessary for 95% confidence that an outbreak is over after 42 days without symptomatic cases. With weaker surveillance, unrecognised transmission may still occur: if the surveillance sensitivity is only 40%, then 62 days must be waited for 95% certainty. By quantifying the certainty in end-of-outbreak declarations, public health decision-makers can plan and communicate more effectively.

epidemiology↗
bioRxiv2018

Geographical Distributions and Spatial Equilibrium in Historical Epidemics of the United States

This research examines the geographical distributions of several historical epidemics in the United States and investigates whether they reached a geographical equilibrium, however briefly. An equilibrium distribution over a geographical area, as the end state of a diffusion or spatial contagion process, has definitive mathematical properties. These permit qualitative and quantitative tests that may confirm an equilibrium and identify its characteristics. The analysis uses United States state-level data for several common infectious diseases of the 1950s, and results show geographical equilibrium distributions for several epidemics. These are not predicted by the most commonly used epidemiological models but are consistent with observed geographical disparities in disease prevalence that continued over a number of years in spite of recurrent epidemic cycles and long-term trends.

epidemiology↗